e-Profile Login and ID Quick Search
News tagged fda
DEA Guidance Regarding Information Pharmacists May Provide on CS II Prescriptions
Recognizing that pharmacists are sometimes presented with prescriptions for Schedule II controlled substances that are missing information required by law, Drug Enforcement Administration provides guidance for pharmacists regarding allowed changes or additions to such prescriptions.
Read More →Nominations for 2014 NABP Annual Awards Now Being Accepted
NABP invites you to nominate a colleague or board of pharmacy for a 2014 NABP award.
Read More →FDA Provides New Information About Lack of Sterility Assurance for Drugs Dispensed by The Compounding Shop
Food and Drug Administration (FDA) is warning patients and health care providers that budesonide solution (for nasal irrigation), dispensed by The Compounding Shop of St Petersburg, FL, may be contaminated and should not be used or administered to patients.
Read More →FDA Requires Changes to Fentanyl Pain Patch Warnings
To reduce the risk of accidental exposure, FDA has announced new requirements that change the appearance of fentanyl pain patch warnings to make them more visible.
Read More →FDA Proposes Labeling Changes for ER/LA Opioids to Combat Abuse, Mandates Post-market Research
To combat the misuse and abuse of extended-release and long-acting (ER/LA) opioids, Food and Drug Administration (FDA) is announcing class-wide label changes to ER/LA opioids, including a statement indicating the medications should be prescribed when the patient requires constant treatment of severe pain and when alternative methods are inadequate.
Read More →University Compounding Pharmacy Recalls Some Products Due to Lack of Sterility Assurance
Food and Drug Administration (FDA) and University Compounding Pharmacy of San Diego, CA, have issued a voluntary recall of several products.
Read More →New FDA Drug Info Rounds Training Video
FDA Drug Info Rounds, a series of online videos, provides important and timely drug information to practicing clinical and community pharmacists.
Read More →FDA: Fluoroquinolone Drug Labels Must Provide Better Descriptions of Peripheral Neuropathy
Food and Drug Administration updated its label requirements for the drug labels on fluoroquinolone-based medications.
FDA Reminds Health Care Providers to Not Use NuVision Pharmacy Products
After NuVision Pharmacy refused FDA’s most recent request to recall all of its sterile products, FDA is reminding health care providers not to use NuVision sterile products.
CHPA Files Petition to Expand Dosing Information on Acetaminophen Products for Young Children
The Consumer Healthcare Products Association (CHPA) has filed a citizen petition to FDA that asks the agency to provide convenient and accurate access to dosing information for children ages six months to two years.
